Posted inBiotechnology
Scientists Overcome Antimicrobial Resistance in Bacteria Linked to Cystic Fibrosis
In a groundbreaking study published in eLife, researchers from The University of Texas at Austin and Imperial College London have…
Posted inBiotechnology
Breakthrough Antimicrobial Shows Promise for Medical and Agricultural Applications
Antimicrobial resistance has emerged as a dire global challenge, threatening both human health and food security with escalating urgency. In…
Posted inBiotechnology
Invasive Neurally-Adjusted Ventilation Feasibility in Severe CDH
In a groundbreaking study poised to reshape neonatal intensive care, researchers have unveiled promising results on the use of invasive…
Posted inBiotechnology
Scientists Pioneer Affordable Method to Convert Waste into Renewable Natural Gas
In a groundbreaking pilot study emerging from Pullman, Washington, researchers have unveiled a transformative approach to sewage sludge treatment, heralding…
Posted inBiotechnology
Genomic Insights Into Human Brain Evolution
The human brain stands as one of the most complex and fascinating organs in the animal kingdom, underlying the unique…
Posted inBiotechnology
Neonatal Nutrition Strategies for Complex Heart Defects
In a groundbreaking national survey published in the Journal of Perinatology in April 2026, researchers have illuminated the intricate landscape…
Posted inGenetics
AACR 2026: A Video Update from San Diego
Podcast Touching Base Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating…
Posted inBiotechnology
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
Roche has shared details of fatalities in its phase 3 relapsing multiple sclerosis (RMS) trials, revealing that deaths from infections,…
Posted inBiotechnology
Tortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia
A pair of Sage Therapeutics veterans has launched a neurology-focused startup armed with $106 million and a clinical-stage pipeline of…
Posted inBiotechnology
Ray Therapeutics shines a light on $125M round targeting genetic eye therapy
Gene therapy biotech Ray Therapeutics has announced the closing of a $125 million series B financing to support the company’s…